FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Huller Kelly 2. Date of Event Requiring Statement (Month/Day/Year) 02/27/2019 3. Issuer Name and Ticker or Trading Symbol GLOBUS MEDICAL INC [GMED] (Last) (First) (Middle) VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) SVP, General Counsel 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) AUDUBON, PA 19403 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Class A Common Stock 15,384 D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy Class A Common Stock)	  (1)	06/16/2020	Class A Common Stock	3,076	$ 11.86	D	Â
Stock Option (Right to Buy Class A Common Stock)	  (2)	02/11/2021	Class A Common Stock	23,076	$ 11.28	D	Â
Stock Option (Right to Buy Class A Common Stock)	  (3)	08/29/2022	Class A Common Stock	2,500	$ 15.34	D	Â
Stock Option (Right to Buy Class A Common Stock)	  (4)	01/30/2023	Class A Common Stock	7,500	$ 12.59	D	Â
Stock Option (Right to Buy Class A Common Stock)	  (5)	03/04/2024	Class A Common Stock	7,500	$ 24.9	D	Â
Stock Option (Right to Buy Class A Common Stock)	  (6)	04/01/2025	Class A Common Stock	7,500	$ 25.8	D	Â
Stock Option (Right to Buy Class A Common Stock)	  (7)	02/02/2026	Class A Common Stock	7,500	$ 24.21	D	Â
Stock Option (Right to Buy Class A Common Stock)	  (8)	02/02/2027	Class A Common Stock	7,500	$ 25.96	D	Â
Stock Option (Right to Buy Class A Common Stock)	  (9)	02/02/2028	Class A Common Stock	10,000	$ 45.64	D	Â
Stock Option (Right to Buy Class A Common Stock)	  (10)	01/22/2029	Class A Common Stock	40,000	$ 43.58	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Huller Kelly VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON, PA 19403	Â	Â	  SVP, General Counsel	Â

Signatures

/s/ Kelly G. Huller		03/06/2019
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	These options were granted on June 16, 2010 and are fully vested.
(2)	These options were granted on February 11, 2011 and are fully vested.
(3)	These options were granted on August 29, 2012 and are fully vested.
(4)	These options were granted on January 30, 2013 and are fully vested.
(5)	These options were granted on March 4, 2014 and are fully vested.
(6)	These options were granted on April 1, 2015 and are fully vested.
(7)	These options were granted on February 2, 2016, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(8)	These options were granted on February 2, 2017, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(9)	These options were granted on February 2, 2018, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(10)	These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.